These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38802026)

  • 21. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
    Wu M; Ping H; Wang K; Ding H; Zhang M; Yang Z; Du Q
    Int J Pharm; 2023 Nov; 647():123510. PubMed ID: 37839497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice.
    Hudcovic T; Kolinska J; Klepetar J; Stepankova R; Rezanka T; Srutkova D; Schwarzer M; Erban V; Du Z; Wells JM; Hrncir T; Tlaskalova-Hogenova H; Kozakova H
    Clin Exp Immunol; 2012 Feb; 167(2):356-65. PubMed ID: 22236013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic protection of astragalus polysaccharides and matrine against ulcerative colitis and associated lung injury in rats.
    Yan X; Lu QG; Zeng L; Li XH; Liu Y; Du XF; Bai GM
    World J Gastroenterol; 2020 Jan; 26(1):55-69. PubMed ID: 31933514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research progress of colon-targeted oral hydrogel system based on natural polysaccharides.
    Wang D; Wang W; Wang P; Wang C; Niu J; Liu Y; Chen Y
    Int J Pharm; 2023 Aug; 643():123222. PubMed ID: 37454829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrageenan: A Wonder Polymer from Marine Algae for Potential Drug Delivery Applications.
    Qureshi D; Nayak SK; Maji S; Kim D; Banerjee I; Pal K
    Curr Pharm Des; 2019; 25(11):1172-1186. PubMed ID: 31465278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
    Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
    J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo study of pH-sensitive and colon-targeting P(LE-IA-MEG) hydrogel microspheres used for ulcerative colitis therapy.
    Shi X; Yan Y; Wang P; Sun Y; Zhang D; Zou Y; Hu S; Zhang L; Xing J; Dong Y
    Eur J Pharm Biopharm; 2018 Jan; 122():70-77. PubMed ID: 29017953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
    Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
    J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis.
    Zhang M; Merlin D
    Inflamm Bowel Dis; 2018 Jun; 24(7):1401-1415. PubMed ID: 29788186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis.
    Luo Y; Fu S; Liu Y; Kong S; Liao Q; Lin L; Li H
    J Ethnopharmacol; 2024 May; 326():117990. PubMed ID: 38423412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysaccharide hydrogels for modified release formulations.
    Coviello T; Matricardi P; Marianecci C; Alhaique F
    J Control Release; 2007 May; 119(1):5-24. PubMed ID: 17382422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A topical thermosensitive hydrogel system with cyclosporine A PEG-PCL micelles alleviates ulcerative colitis induced by TNBS in mice.
    Xiao C; Li G; Li X; Wang D; Wu Y; Sun M; Huang J; Si L
    Drug Deliv Transl Res; 2023 Oct; 13(10):2447-2462. PubMed ID: 37060530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally ingestible medication utilizing layered double hydroxide nanoparticles strengthened alginate and hyaluronic acid-based hydrogel bead for bowel disease management.
    Nguyen NT; Nguyen BT; Ho TN; Tran CD; Tran TH; Nguyen HH; Nguyen HP; Huynh NT; Li Y; Phan VHG; Thambi T
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132122. PubMed ID: 38718992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
    Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
    Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
    Li J; Chen C; Cao XN; Wang GH; Hu JB; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):59-65. PubMed ID: 24496680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
    Hartman DS; Tracey DE; Lemos BR; Erlich EC; Burton RE; Keane DM; Patel R; Kim S; Bhol KC; Harris MS; Fox BS
    J Crohns Colitis; 2016 Jun; 10(6):641-9. PubMed ID: 26802087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel biodegradable pH-sensitive hydrogels: An efficient controlled release system to manage ulcerative colitis.
    Abbasi M; Sohail M; Minhas MU; Khan S; Hussain Z; Mahmood A; Shah SA; Kousar M
    Int J Biol Macromol; 2019 Sep; 136():83-96. PubMed ID: 31195039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.